Outcome of Board Meeting

Date: 07-11-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam, Subject: Outcome of the Board Meeting held on 7th November 2026. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being in force), this is to inform you that the Board of Directors of the Company (“Board”) at their meeting held today i.e. Saturday, 7th November 2026, have inter-alia considered and approved the following business: 1. Financial Results: The unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended 30th September 2026 is enclosed. Further, the Limited Review Report received from the Statutory Auditors of the Company is also enclosed. 2. Revised the terms of investment in Swaccha Eco Solutions Private Limited (SESPL): The Board has approved to revise the terms of investment proposed to be made in SESPL by subscribing to 85,200 equity shares at a price of ₹250/- per share, aggregating to a total investment of ₹2,13,00,000/- (Rupees Two Crore Thirteen Lakhs Only) representing 46% of the paid-up capital, thereby making SESPL an associate of the Company. The detailed disclosure as required under SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 and such other circulars as applicable, in respect of Sl. No. 2 is enclosed as Annexure I. The Meeting commenced at 11:35 a.m. and concluded at 11:55 a.m. This is for your information and records. Thank you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502 Encl: as above. SHAH & TAPARIA CH ARTERED ACCOUNTANTS 203, Center Point Building, 100, Dr. Babasaheb Ambedkar Road, Opp. Bharatmata Theater, Lalbaug, Parel, Mumbai - 400 012. Tel.: 022 - 42116800 Fax : 022-4022 0314 E-mail : Info@shahtaparia.com Visit us at : www.shahtaparia.com Independent Auditor’s Review Report on Quarterly and Year to Date Unaudited Consolidated Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Mukka Proteins Limited 1. We have reviewed the accompanying Statement of Unaudited Consolidated Financial Results of Mukka Proteins Limited (“the Parent”), its subsidiaries (the Parent and its subsidiaries together referred to as “the Group”) and Group’s share of the net profit/loss after tax and total comprehensive income/loss of its joint ventures, for the quarter and half year ended September 30, 2026 (‘the Statement’) attached herein, being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This Statement, which is the responsibility of the Parent’s Management and approved by the Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of Parent’s personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion, We also performed procedures in accordance with the Circular No. CIR/CFD/CMDI/44/2019 dated March 29, 2019 issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable. Delhi Office : 52/74, Basement, Ramjas Road, Karol Baugh, New Delhi - 110005. @ Tel.: 011-46051136 / 011-79632863 @ E-mail : delhi@shahtaparia.com SHAH & TAPARIA CHARTERED ACCOUNTANTS 203, Center Point Building, 100, Dr. Babasaheb Ambedkar Road, Opp. Bharatmata Theater, Lalbaug, Parel, Mumbai - 400 012. Tel.: 022 - 42116800 Fax : 022-4022 0314 E-mail : Info@shahtaparia.com Visit us at : www.shahtaparia.com 4. The Statement includes the results of the following entities: Name of the Entity Relationship Mukka Proteins Limited Parent Company Haris Marine Products Private Limited Wholly Owned Subsidiary Company (Domestic) Atlantic Marine Products Private Limited Subsidiary Company (Domestic) Ocean Aquatic Proteins LLC Subsidiary Company (Foreign) Ento Proteins Private Limited Wholly Owned Subsidiary Company (Domestic) Fabbco Bio Cycle and Bio Protein Techno logy Subsidiary Company (Domestic) Private Limited Ocean Proteins Private Limited Subsidiary Company (Domestic) United Gulf Fishery Products LLC Subsidiary Company (Foreign) Mukka Frozen Impex Subsidiary Entity (Domestic) MPL HRC Eco Solution LLP Subsidiary Entity (Domestic) Delta Marine Products Subsidiary Entity (Domestic) Ullal Fish Meal and Oil Company Joint Venture GSM Marine Export Joint Venture Progress Frozen and Fish Sterilization Joint Venture Pacific Marine Products Joint Venture Mangalore Fishmeal and Oil Company Joint Venture — Indirect 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompany ing Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in Delhi Office : 52/74, Basement, Ramjas Road, Karol Baugh, New Delh i - 110005. @ Tel.: 011-46051136 / 011-79632863 @ E-mail : delhi@shahtaparia.com SHAH & TAPARIA CHARTERE D ACCOUNTANTS 203, Center Point Building, 100, Dr. Babasaheb Ambedkar Road, Opp. Bharatmata Theater, Lalbaug, Parel, Mumbai - 400 012. Tel.: 022 - 42116800 Fax : 022-4022 0314 E-mail : Info@shahtaparia.com Visit us at : www.shahtaparia.com India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We did not review the interim financial information/ financial results of ten subsidiaries included in the Statement, whose interim financial information/ financial results reflect total assets of Rs. 4568.87 million as at September 30, 2026, total revenues of Rs. 1,859.71 and Rs. 3371.17 million, total net profit after tax of Rs. 78.42 million and Rs.70.61 million and _ total comprehensive income of Rs. 76.70 and Rs. 64.55 million for the quarter and half year ended September 30, 2026 respectively and net cashflow of Rs. 107.39 million for the half year ended September 30, 2026 as considered in the Statement which have been reviewed by other auditors, whose reports has been furnished to us by the Company’s management [Showing first 8,000 characters — download PDF for full document]